DAIICHI KIGENSO KAGAKU-KOGYO CO.,LTD FY2027 Q1 Earnings Report

Quick View

Executive Summary

In addition to higher revenue and profit, the quarter was characterized by an improvement in the operating margin and a return to net profitability due to foreign exchange gains. Revenue was ¥101.1B (¥81.0B in the same period last year, YoY +24.9%), Operating Income was ¥11.5B (¥5.2B, YoY +119.4%), Ordinary Income was ¥14.1B (¥0.1B), and Net Income returned to profitability at ¥9.6B (¥-0.0B). The increase in revenue was primarily attributable to expanded sales volume. Operating margin improved to 11.4% due to SG&A expense controls, while foreign exchange gains of ¥4.0B further boosted Ordinary Income and Net Income.

Factors Affecting Performance

【Revenue】Revenue increased 24.9% year on year to ¥101.1B. The Company operates as a single segment (manufacturing and sales of chemical industrial products), and expanded sales volume appears to have been the primary driver of the revenue increase. Cost of sales increased alongside revenue to ¥71.9B, while the gross margin declined slightly to 28.9% from 29.4% in the same period last year, a decrease of -59bp.

【Profit and Loss】Operating Income increased 119.4% YoY to ¥11.5B, and the operating margin improved by +491bp to 11.4% from 6.5% in the same period last year. Despite the decline in gross margin, the decrease in SG&A expenses to ¥17.7B (¥18.6B in the same period last year) was the primary factor behind the improvement in operating margin. Ordinary Income was ¥14.1B; foreign exchange gains of ¥4.0B boosted non-operating income and significantly increased Net Income, exceeding interest expenses of ¥1.2B. Net Income was ¥9.6B, representing a return to profitability from the nominal loss recorded in the same period last year. Extraordinary gains and losses were nearly zero, and the difference between Ordinary Income and Net Income was a standard one attributable to income taxes and other taxes of ¥4.5B (effective tax rate: 32.0%). The quarter was characterized by higher revenue and profit, with both cost controls at the operating level and the temporary factor of foreign exchange gains contributing to the results.

Segment Analysis

The Company operates as a single segment comprising the manufacture and sale of chemical industrial products, and does not disclose results by segment.

Key Financial Indicators

【Profitability】The operating margin improved to 11.4% from 6.5% in the same period last year, while the net margin turned positive at 9.4% (a nominal loss in the same period last year). The gross margin declined slightly to 28.9%, down -59bp from the previous year, and the improvement in operating margin was primarily attributable to SG&A expense controls.【Cash Flow Quality】Raw materials increased to ¥57.0B, while accounts receivable and notes receivable also remained high at ¥70.6B. The expansion of working capital alongside the increase in Operating Income requires monitoring from the perspective of capital efficiency.【Investment Efficiency】ROE was 2.4%. Compared with the return to net profitability, the low total asset turnover (an asset-intensive structure) continues to constrain capital efficiency.【Financial Soundness】The Equity Ratio remained high at 60.2%. Short-term borrowings decreased substantially year on year compared with long-term borrowings of ¥143.5B, while cash and deposits totaled ¥91.4B, indicating a stable financial base.

Cash Flow Analysis

Although detailed information on the statement of cash flows is not included in the disclosed data, cash trends can be assessed from movements in the balance sheet. The increase in raw materials to ¥57.0B (+31% year on year) and in accounts receivable and notes receivable to ¥70.6B indicates an expansion in working capital associated with higher revenue. Meanwhile, cash and deposits declined to ¥91.4B from ¥111.4B in the same period last year, while short-term borrowings decreased substantially from ¥22.0B to ¥5.0B. This can be interpreted as the simultaneous progress of a review of the funding structure and investment of funds into inventories and accounts receivable. Whether the expansion in Operating Income is translating sufficiently into cash generation will depend on improvements in inventory and receivables turnover.

Earnings Quality

The increase in profit for the current period comprised both a structural improvement at the operating level through SG&A expense controls and the temporary factor of ¥4.0B in foreign exchange gains. Foreign exchange gains accounted for ¥4.0B of non-operating income of ¥4.8B, making a substantial contribution to the increase in Ordinary Income to ¥14.1B. Meanwhile, interest expenses of ¥1.2B represented a major component of non-operating expenses, and the fact that foreign exchange gains exceeded these expenses contributed to the return to net profitability. Extraordinary gains and losses were virtually absent, and Net Income of ¥9.6B, calculated by deducting income taxes and other taxes of ¥4.5B from pre-tax income of ¥14.1B, reflected a standard effective tax rate of 32.0%. Comprehensive Income was ¥8.4B, slightly below Net Income of ¥9.6B, as other comprehensive income items such as foreign currency translation adjustments of ¥-0.6B and valuation differences on securities of ¥-0.4B had a negative impact. While the improvement at the operating level is expected to be sustainable, foreign exchange gains are a temporary factor that may fluctuate depending on market conditions.

Earnings Forecasts and Guidance

Progress against the full-year forecast was 27.3% for Revenue, 38.4% for Operating Income, and 70.3% for Ordinary Income. Net Income was not disclosed in the forecast, but the ¥9.6B achieved represents 64.0% of the Company’s planned Net Income of ¥15.0B. Progress in Ordinary Income and Net Income substantially exceeded progress in Revenue and Operating Income, reflecting the boost from the non-operating factor of foreign exchange gains. The full-year Company plan calls for Operating Income to decline YoY by -13.8% and Ordinary Income to decline YoY by -38.6%, suggesting that the plan may assume the contribution from foreign exchange gains in the first half will abate from the second half onward. No revisions to the earnings forecasts had been made as of this quarter.

Shareholder Returns

The Company’s annual dividend plan is ¥30.00 per share (an increase from ¥14 in the previous year). The Payout Ratio against the Company’s planned EPS of ¥62.12 is approximately 48.3%. With an Equity Ratio of 60.2% and a favorable interest coverage ratio, the Company has sufficient financial capacity to maintain dividend payments. No disclosure regarding share repurchases was identified.

Risk Factors

1. Foreign Exchange Risk: Foreign exchange gains of ¥4.0B significantly boosted Ordinary Income during the quarter. This contribution is a temporary factor that could reverse depending on market conditions, and its sustainability for the full year is uncertain.

2. Inventory and Working Capital Risk: Raw materials increased to ¥57.0B (approximately +31% from ¥43.4B in the previous year), while finished products reached ¥80.9B. Although part of the increase reflects inventory accumulation in response to higher revenue, it entails risks of inventory valuation losses and deteriorating turnover efficiency.

3. Asymmetric Revenue and Profit Progress Risk: Full-year progress is substantially ahead for Ordinary Income at 70.3% compared with 27.3% for Revenue, and the pace of progress may change if non-operating factors, particularly foreign exchange gains, abate in the second half.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Company’s operating margin and net margin exceed the industry median, placing its profitability relatively high within the industry.

Growth and Capital Efficiency

The Revenue growth rate substantially exceeds both the industry median and the upper bound of the IQR, demonstrating high growth within the industry.

※Source: Compiled by the Company

Key Points from the Financial Results

1. In addition to higher revenue, the operating margin improved through SG&A expense controls (+491bp), confirming fundamental earnings improvement in the cost structure.

2. The increase in Ordinary Income and Net Income was heavily dependent on foreign exchange gains of ¥4.0B. The high level of full-year progress (70.3% for Ordinary Income) must therefore be viewed in light of the inclusion of temporary factors.

3. The increase in raw material inventories and the high level of accounts receivable indicate an expansion of working capital associated with higher revenue. Inventory and collection management will be key areas to monitor going forward.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥1,353–¥1,430 at ±1% for the cost of equity, and ¥1,383–¥1,396 at ±0.1 for ω.

Notes:

• Because progress in Net Income against the full-year forecast (64%) exceeds the standard level (25%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies ahead of schedule tend to outperform their forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Net Income is significantly compressed relative to Operating Income due to tax burdens, acquisition-related expenses, and non-controlling interests, among other factors (Net Income ÷ Operating Income: 50%). This figure reflects that compression at face value; if the factors are temporary, underlying earnings power may be higher.
• Because forecast ROE is below the cost of equity, the theoretical value is below Book Value per Share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-07 / This figure does not predict or guarantee future share prices)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a strong operating recovery, although reported bottom-line strength was materially amplified by foreign-exchange gains. Revenue increased 24.9% year on year to ¥10.11bn. Operating income more than doubled, rising 119.4% to ¥1.15bn. The operating margin expanded by 491bp year on year to 11.4% from 6.5%. Gross profit rose 22.4% to ¥2.92bn, but the gross margin declined 54bp to 28.9%, indicating that the earnings improvement was driven principally by SG&A leverage rather than gross-margin expansion. SG&A expense declined 5.0% year on year to ¥1.77bn despite the substantial sales increase. Consequently, SG&A as a percentage of revenue fell to 17.5% from 23.0% in the prior-year quarter. Ordinary income surged to ¥1.41bn from ¥0.02bn, and profit attributable to owners of parent reached ¥0.95bn, compared with essentially break-even earnings a year earlier. Foreign-exchange gains of ¥0.40bn represented 34.4% of operating income and were the principal reason ordinary income exceeded operating income by ¥0.25bn. Net margin was 9.4%, a solid level, but below the 10% threshold generally associated with excellent profitability. The annualized ROE of 9.6% reflects improved profitability, supported by 0.616x annualized asset turnover and 1.66x financial leverage. Liquidity is very strong, with a 356.2% current ratio and ¥25.38bn of working capital. Debt risk is manageable based on a 0.66x debt-to-equity ratio, 27.3% debt-to-capital ratio, and 9.93x interest coverage. However, the working-capital cycle is a material operational issue: annualized DSO is 64 days, annualized inventory days are 215 days, and the annualized cash conversion cycle is 256 days. Q1 operating income has already achieved 38.4% of the full-year plan, ahead of the standard 25% seasonal progress rate, while ordinary income and net income have achieved 70.3% and 63.5%, respectively, largely reflecting the FX benefit. Management has not revised either earnings or dividend guidance, implying that the company does not yet treat the Q1 non-operating contribution as a basis for higher full-year expectations. The core issue for subsequent quarters is whether volume growth and SG&A discipline can sustain operating profit as currency gains normalize and high inventory is converted into cash.

Profitability Analysis

The annualized DuPont ROE is 9.6%, comprising a 9.4% net profit margin, 0.616x annualized asset turnover, and 1.66x financial leverage. The most significant change in the earnings structure was profitability: operating margin rose to 11.4% from 6.5%, while net income recovered from approximately break-even in the prior-year quarter. Revenue growth of 24.9% was well ahead of the 5.0% decline in SG&A expenses, demonstrating powerful operating leverage. Gross margin, however, declined to 28.9% from 29.4%, so the operating-margin improvement did not stem from better production economics at the gross-profit level. This makes continued control of overheads and sustained utilization important to maintaining the Q1 operating margin. Ordinary income margin reached 13.9%, exceeding the operating margin because ¥0.40bn of FX gains more than offset ¥0.22bn of non-operating expenses, including ¥0.12bn of interest expense. The 5-factor analysis shows a 67.8% tax burden and a 1.220 interest burden; the latter being above 1.0 confirms that non-operating income, rather than financing structure, lifted pre-tax earnings above EBIT. The 32.0% effective tax rate is broadly normal and does not appear to be the source of the earnings rebound. Financial leverage of 1.66x contributes to ROE but is not aggressive given the 0.66x debt-to-equity ratio. Annualized asset turnover of 0.616x is moderate for a capital-intensive specialty-chemical manufacturer with PPE equal to 37.5% of assets. Profitability is therefore meaningfully improved, but the sustainability of the net-income margin is lower than that of the operating recovery because currency gains accounted for a substantial part of the gap between operating and ordinary profit.

Growth Assessment

Top-line momentum was strong in Q1, with revenue rising ¥2.01bn year on year to ¥10.11bn. The sales increase translated into a ¥0.63bn increase in operating income, demonstrating that incremental revenue was converted efficiently into operating profit despite a modest 54bp gross-margin contraction. The principal recurring growth signal is the reduction in SG&A expense from ¥1.86bn to ¥1.77bn alongside higher sales. The single chemical-products manufacturing and sales segment is the core business, generating all disclosed revenue and operating income. Q1 revenue progress against the ¥37.0bn full-year forecast was 27.3%, 2.3 percentage points above the standard 25% Q1 benchmark. Q1 operating-income progress was 38.4% against the ¥3.0bn full-year forecast, 13.4 percentage points above the standard benchmark, indicating a stronger-than-planned start or a conservative full-year operating-profit assumption. Ordinary-income progress was 70.3% against the ¥2.0bn forecast, 45.3 percentage points above the standard benchmark. Profit attributable to owners progress was 63.5% against the ¥1.5bn forecast, 38.5 percentage points above the standard benchmark. The exceptional outperformance at ordinary and net-income levels is not fully representative of recurring operations because Q1 FX gains were ¥0.40bn. At the Q1 run rate, annualized operating income would be approximately ¥4.61bn, well above the current ¥3.0bn guidance, but this annualized figure should not be interpreted as a forecast because quarterly demand, pricing, cost absorption, and currency effects can vary materially. The unchanged guidance suggests management expects normalization later in the fiscal year. High inventories, particularly finished goods, should be monitored as an indicator of whether Q1 sales growth reflects durable demand rather than inventory build ahead of shipment.

Financial Health

The balance sheet is liquid and adequately capitalized. Current assets of ¥35.29bn exceed current liabilities of ¥9.91bn by ¥25.38bn, producing a 356.2% current ratio and an equivalent 356.2% quick ratio. Cash and deposits of ¥9.14bn alone are 18.27 times short-term loans of ¥0.50bn. Interest-bearing debt totals ¥14.85bn, equivalent to 0.66x total equity, while debt-to-capital is a conservative 27.3%. Interest coverage of 9.93x indicates that Q1 EBIT of ¥1.15bn comfortably covered ¥0.12bn of interest expense. There is no current-ratio warning and no debt-to-equity warning under the stated thresholds. Short-term loans fell sharply by ¥1.70bn year on year to ¥0.50bn, reducing near-term refinancing pressure. Long-term loans increased by ¥0.28bn to ¥14.35bn, leaving the funding profile predominantly long-term. Current portions of long-term loans were ¥5.42bn, but they remain covered by cash and deposits and by the substantially larger working-capital surplus. Equity increased to ¥39.53bn from ¥39.02bn, and the capital adequacy ratio improved to 59.3% from 57.5%. PPE represents 37.5% of assets, consistent with a capital-intensive manufacturing profile; therefore, maintaining sufficient long-term funding and operating cash generation remains important. Deferred tax liabilities were ¥0.27bn, while employee-related provisions include ¥2.24bn for bonuses and ¥1.12bn for directors' bonuses. The balance sheet supports ongoing operations, but the concentration of debt in long-term borrowings means interest-rate conditions and the returns earned on production assets remain relevant solvency considerations.

Notable B/S Changes

Short-term loans: -¥1.70bn (-77.3%) to ¥0.50bn — materially reduced short-term borrowing and improved the near-term funding profile. Cash and deposits: -¥2.00bn (-18.0%) to ¥9.14bn — liquidity remains strong, but the decline heightens the importance of cash conversion from receivables and inventory. Raw materials: +¥1.36bn (+31.3%) to ¥5.70bn — increased input inventory raises exposure to demand, procurement-price, and working-capital risks. Work in process: +¥0.32bn (+11.1%) to ¥3.19bn — production inventory increased and should be monitored alongside shipment growth and utilization. Accounts receivable: +¥0.43bn (+6.4%) to ¥7.06bn — receivables growth, together with 64-day annualized DSO, indicates slower-than-benchmark collection efficiency. Total liabilities: -¥1.73bn (-6.2%) to ¥26.14bn — balance-sheet deleveraging was driven primarily by lower short-term loans. Property, plant and equipment: -¥0.18bn (-0.7%) to ¥24.63bn — the production asset base remains substantial at 37.5% of total assets, underscoring the need for sustained asset utilization.

Cash Flow Quality

The operating cash flow, investing cash flow, financing cash flow, free cash flow, and capital-expenditure figures are not reported in the supplied financial data, so cash conversion and free-cash-flow coverage cannot be quantified. Balance-sheet working-capital metrics nevertheless indicate elevated cash absorption risk. Annualized receivable days are 64, exceeding the 60-day warning level; accounts receivable increased ¥0.43bn year on year to ¥7.06bn. Annualized inventory days are 215, far above the 90-day warning threshold for manufacturing companies. Total disclosed inventories were ¥16.98bn, comprising ¥5.70bn of raw materials, ¥3.19bn of work in process, and ¥8.09bn of finished goods. Finished goods account for 47.6% of disclosed inventories, making demand realization, inventory valuation, and potential obsolescence central monitoring items. Raw materials increased by ¥1.36bn and work in process by ¥0.32bn year on year, while finished goods declined by ¥0.45bn. The annualized cash conversion cycle is 256 days, well above the 120-day warning level. Implied annualized payable days are approximately 23 days, below the 30-60 day benchmark and indicating relatively limited supplier-credit support for the working-capital cycle. These conditions raise the risk that accounting earnings may not convert promptly into operating cash. The Q1 foreign-exchange gain of ¥0.40bn is also non-cash or timing-sensitive from an earnings-quality perspective and should not be equated automatically with recurring cash generation. Cash and deposits declined ¥2.00bn year on year to ¥9.14bn, reinforcing the importance of inventory monetization and receivables collection.

Dividend Sustainability

The full-year dividend forecast is ¥30 per share, unchanged from management's prior guidance. Based on forecast EPS of ¥62.12, the implied dividend payout ratio is 48.3%. This is below the 60% sustainability benchmark and leaves a reasonable earnings retention buffer. Q1 EPS was ¥39.46, already 63.5% of full-year forecast EPS, but this early progress includes a substantial FX-gain contribution and should not be extrapolated directly. The company has substantial equity of ¥39.53bn and a strong liquidity position, which support dividend capacity. However, the long cash conversion cycle and high inventory intensity make cash realization more important than the accounting payout ratio alone. Dividend sustainability is therefore supported by forecast earnings and balance-sheet strength, while the practical scope for additional shareholder distributions depends on the conversion of working capital into operating cash.

Risk Assessment

Business risks include Demand and inventory risk: annualized inventory days of 215 and finished-goods inventory of ¥8.09bn create exposure to slower customer demand, price reductions, inventory write-downs, and lower factory utilization., Specialty-chemical cost and margin risk: gross margin declined 54bp year on year to 28.9%, indicating that revenue growth has not yet translated into gross-margin expansion and leaving profitability exposed to raw-material, energy, and product-mix changes., Foreign-exchange risk: FX gains of ¥0.40bn equaled 34.4% of operating income, above the 20% warning threshold. Currency movements can therefore cause significant volatility in ordinary income and net income., Manufacturing asset-utilization risk: PPE of ¥24.63bn, or 37.5% of assets, requires sustained production volumes and adequate returns to support asset productivity and debt servicing., Chemical-industry regulatory and environmental risk: operations remain exposed to tightening environmental regulation, hazardous-substance handling requirements, emissions controls, and remediation obligations..

Financial risks include Working-capital risk: annualized DSO of 64 days, annualized DIO of 215 days, and an annualized CCC of 256 days point to slow cash conversion and potential reliance on liquidity during demand fluctuations., Interest-rate and funding risk: interest-bearing debt of ¥14.85bn is manageable relative to equity, but long-term loans of ¥14.35bn make future borrowing costs and refinancing conditions relevant., Earnings-composition risk: ordinary income exceeded operating income by ¥0.25bn because of non-operating gains, reducing the repeatability of Q1 pre-tax earnings..

Key concerns include Highest priority: inventory conversion and valuation. The 215-day annualized inventory holding period is substantially above manufacturing benchmarks and represents the most direct risk to cash generation., High priority: currency sensitivity. The FX contribution was large enough to distort comparison between underlying operating profit and reported ordinary/net income., Moderate priority: sustaining SG&A leverage. Q1 operating-margin expansion depended on SG&A declining while revenue grew rapidly, whereas gross margin modestly weakened., Moderate priority: full-year forecast quality. Q1 operating profit materially exceeded a straight-line run rate, while ordinary and net profit substantially exceeded it; unchanged guidance implies expected normalization..

Investment Implications

Key takeaways include Revenue growth of 24.9% and operating-income growth of 119.4% demonstrate a clear Q1 operating turnaround., Operating margin improved 491bp to 11.4%, driven by strong SG&A leverage rather than gross-margin expansion., Reported earnings were enhanced by ¥0.40bn of FX gains, equal to 34.4% of operating income, requiring separation of recurring operating momentum from currency effects., Liquidity and capitalization are strong, with a 356.2% current ratio, 0.66x debt-to-equity, and 9.93x interest coverage., Inventory and receivable efficiency are the main constraints on earnings-to-cash conversion, with annualized DIO of 215 days, DSO of 64 days, and CCC of 256 days., The forecast ¥30 DPS implies a 48.3% payout ratio on forecast EPS and appears earnings-supported..

Metrics to watch include Quarterly revenue growth and operating margin versus the Q1 11.4% level, Gross margin, which was 28.9% in Q1 versus 29.4% a year earlier, SG&A-to-sales ratio, which improved to 17.5% from 23.0%, FX gains/losses relative to operating income, Annualized inventory days, finished-goods balances, and potential inventory valuation charges, Annualized DSO, payable days, and cash conversion cycle, Operating cash flow and free cash flow relative to net income and dividend commitments, Progress toward full-year forecasts of ¥37.0bn revenue, ¥3.0bn operating income, ¥2.0bn ordinary income, and ¥1.5bn profit attributable to owners.

Regarding relative positioning, The company combines an improving mid-tier operating margin of 11.4% with a strong liquidity profile and conservative leverage relative to the stated solvency benchmarks. Its relative weakness is working-capital efficiency: 64-day receivables, 215-day inventory, and a 256-day cash conversion cycle are materially weaker than standard manufacturing benchmarks. The Q1 earnings profile is also more currency-sensitive than a purely operating-led recovery, as FX gains made a significant contribution to ordinary and net income.